Sameer Agarwal

832 total citations
34 papers, 707 citations indexed

About

Sameer Agarwal is a scholar working on Endocrinology, Diabetes and Metabolism, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Sameer Agarwal has authored 34 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Organic Chemistry and 9 papers in Molecular Biology. Recurrent topics in Sameer Agarwal's work include Synthesis and Characterization of Pyrroles (5 papers), Drug Transport and Resistance Mechanisms (5 papers) and Diabetes Treatment and Management (5 papers). Sameer Agarwal is often cited by papers focused on Synthesis and Characterization of Pyrroles (5 papers), Drug Transport and Resistance Mechanisms (5 papers) and Diabetes Treatment and Management (5 papers). Sameer Agarwal collaborates with scholars based in India, Germany and Spain. Sameer Agarwal's co-authors include Hans‐Joachim Knölker, Wolfgang Fröhner, Micha P. Krahl, Kethiri R. Reddy, Mukul R. Jain, Ulrike Schmidt, Olga Kataeva, Prashant Deshmukh, Padmaja Sudhakar and Kasinath Viswanathan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain Research and Frontiers in Immunology.

In The Last Decade

Sameer Agarwal

31 papers receiving 698 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sameer Agarwal India 12 502 159 56 53 48 34 707
Jacques Y. Roberge United States 15 312 0.6× 343 2.2× 19 0.3× 57 1.1× 66 1.4× 33 605
Katja Hübel Germany 12 486 1.0× 255 1.6× 43 0.8× 24 0.5× 43 0.9× 13 696
Carl Berthelette Canada 19 428 0.9× 200 1.3× 52 0.9× 60 1.1× 35 0.7× 25 705
Paresh K. Patel India 11 252 0.5× 145 0.9× 29 0.5× 26 0.5× 60 1.3× 25 553
H. Sivaramakrishnan India 13 252 0.5× 215 1.4× 40 0.7× 30 0.6× 13 0.3× 28 528
Eugene B. Grant United States 11 414 0.8× 172 1.1× 38 0.7× 13 0.2× 35 0.7× 17 599
Lisbet Kværnø Denmark 16 478 1.0× 364 2.3× 22 0.4× 36 0.7× 12 0.3× 24 813
Jonathan Z. Ho United States 13 182 0.4× 121 0.8× 28 0.5× 41 0.8× 25 0.5× 27 368
Alain Daugan France 9 272 0.5× 366 2.3× 29 0.5× 48 0.9× 43 0.9× 9 595
Alexios N. Matralis Greece 16 216 0.4× 316 2.0× 58 1.0× 40 0.8× 20 0.4× 29 559

Countries citing papers authored by Sameer Agarwal

Since Specialization
Citations

This map shows the geographic impact of Sameer Agarwal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sameer Agarwal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sameer Agarwal more than expected).

Fields of papers citing papers by Sameer Agarwal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sameer Agarwal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sameer Agarwal. The network helps show where Sameer Agarwal may publish in the future.

Co-authorship network of co-authors of Sameer Agarwal

This figure shows the co-authorship network connecting the top 25 collaborators of Sameer Agarwal. A scholar is included among the top collaborators of Sameer Agarwal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sameer Agarwal. Sameer Agarwal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kalra, Sanjay, Vaishali Deshmukh, Ameya Joshi, et al.. (2024). Glycaemic durability and compliance among type 2 diabetes mellitus patients from India: results from the companion survey. International Journal of Community Medicine and Public Health. 11(12). 4742–4750.
2.
Chatterjee, Abhijit, Hiren V. Patel, Harilal Patel, et al.. (2024). A novel selective NLRP3 inhibitor shows disease-modifying potential in animal models of Parkinson’s disease. Brain Research. 1842. 149129–149129. 7 indexed citations
3.
Agarwal, Sameer, et al.. (2022). ZY12201: A Potent TGR5 Agonist: Identification of a Novel Pan CYP450Inhibitor Tool Compound for In-Vitro Assessment. PubMed. 15(2). 116–132. 1 indexed citations
4.
Sudhakar, Padmaja, et al.. (2021). Identification of degradation impurity of TGR5 receptor agonist-ZY12201 by LC–MS technique during force degradation study. SN Applied Sciences. 3(6). 660–660. 2 indexed citations
5.
Jain, Sarika, Shubhangi S. Soman, Padmaja Sudhakar, et al.. (2020). Practical and Efficient Synthesis of 2-Thio-imidazole Derivative—ZY12201: A Potent TGR5 Agonist. Organic Process Research & Development. 24(8). 1508–1514. 5 indexed citations
6.
Agarwal, Sameer, Hardik Shah, Debdutta Bandyopadhyay, et al.. (2020). Identification of a novel orally bioavailable NLRP3 inflammasome inhibitor. Bioorganic & Medicinal Chemistry Letters. 30(21). 127571–127571. 19 indexed citations
7.
Agarwal, Sameer, et al.. (2019). Development of Chromatographic Method for Determination of Impurities in Solid Dispersion of Dasatinib. 5(21). 19–29. 5 indexed citations
8.
9.
Agarwal, Sameer, et al.. (2019). Novel 2-mercapto imidazole and triazole derivatives as potent TGR5 receptor agonists. SHILAP Revista de lepidopterología. 1. 100002–100002. 7 indexed citations
10.
Agarwal, Sameer, Jeevan Kumar, Prashant Deshmukh, et al.. (2018). Evaluation of novel TGR5 agonist in combination with Sitagliptin for possible treatment of type 2 diabetes. Bioorganic & Medicinal Chemistry Letters. 28(10). 1849–1852. 14 indexed citations
11.
Glass, Bärbel, Matthias Giese, Gary Jennings, et al.. (2018). Lipidomimetic Compounds Act as HIV-1 Entry Inhibitors by Altering Viral Membrane Structure. Frontiers in Immunology. 9. 1983–1983. 14 indexed citations
12.
Kalra, Sanjay, Rashmi Aggarwal, Sameer Agarwal, et al.. (2017). Patient-centered management of hypothyroidism. Indian Journal of Endocrinology and Metabolism. 21(3). 475–475. 8 indexed citations
13.
Kalra, Sanjay, AG Unnikrishnan, Mangesh Tiwaskar, et al.. (2017). Medication counseling for thyroxine. Indian Journal of Endocrinology and Metabolism. 21(4). 630–630. 5 indexed citations
14.
Bahekar, Rajesh, et al.. (2017). An Efficient and Scalable Synthesis of tert-Butyl (3aR,6aS)-5-Oxohexahydrocyclo penta[c]pyrrole-2(1H)-carboxylate: A Pharmacologically Important Intermediate. Organic Process Research & Development. 21(2). 266–272. 2 indexed citations
15.
Agarwal, Sameer, Cornelia Schroeder, Georg Schlechtingen, et al.. (2013). Evaluation of steroidal amines as lipid raft modulators and potential anti-influenza agents. Bioorganic & Medicinal Chemistry Letters. 23(18). 5165–5169. 8 indexed citations
16.
Agarwal, Sameer, Olga Kataeva, Ulrike Schmidt, & Hans‐Joachim Knölker. (2012). Silver(i)-promoted oxidative cyclisation to pyrrolo[2,1-a]isoquinolines and application to the synthesis of (±)-crispine A. RSC Advances. 3(4). 1089–1096. 34 indexed citations
17.
Agarwal, Sameer. (2011). Pseudo-Grey Platelet Syndrome: A Rare Artifact. Indian Journal of Hematology and Blood Transfusion. 29(1). 52–54.
18.
Deshpande, Archana, et al.. (2008). Primary cutaneous rhinosporidiosis diagnosed on FNAC: A case report with review of literature. Diagnostic Cytopathology. 37(2). 125–127. 11 indexed citations
19.
Agarwal, Sameer, et al.. (2005). Novel Routes to Pyrroles, Indoles and Carbazoles - Applications in Natural Product Synthesis. Current Organic Chemistry. 9(15). 1601–1614. 182 indexed citations
20.
Agarwal, Sameer & Hans‐Joachim Knölker. (2004). A novel pyrrole synthesis. Organic & Biomolecular Chemistry. 2(21). 3060–3062. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacques Y. Roberge Breakdown of academic impact, for papers by Katja Hübel Breakdown of academic impact, for papers by Carl Berthelette Breakdown of academic impact, for papers by Paresh K. Patel Breakdown of academic impact, for papers by H. Sivaramakrishnan Breakdown of academic impact, for papers by Eugene B. Grant Breakdown of academic impact, for papers by Lisbet Kværnø Breakdown of academic impact, for papers by Jonathan Z. Ho Breakdown of academic impact, for papers by Alain Daugan Breakdown of academic impact, for papers by Alexios N. Matralis
Rankless by CCL
2026